Scibase Financial Statements From 2010 to 2025

SCIB Stock  SEK 0.41  0.02  4.65%   
Scibase AB financial statements provide useful quarterly and yearly information to potential Scibase AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Scibase AB financial statements helps investors assess Scibase AB's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Scibase AB's valuation are summarized below:
Scibase AB does not presently have any fundamental trend indicators for analysis.
Check Scibase AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Scibase AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Scibase financial statements analysis is a perfect complement when working with Scibase AB Valuation or Volatility modules.
  
This module can also supplement various Scibase AB Technical models . Check out the analysis of Scibase AB Correlation against competitors.

Scibase AB Company Return On Equity Analysis

Scibase AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Scibase AB Return On Equity

    
  -0.9  
Most of Scibase AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scibase AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Scibase AB has a Return On Equity of -0.8992. This is 96.25% lower than that of the Healthcare sector and 86.54% lower than that of the Diagnostics & Research industry. The return on equity for all Sweden stocks is 190.06% higher than that of the company.

Scibase AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Scibase AB's current stock value. Our valuation model uses many indicators to compare Scibase AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scibase AB competition to find correlations between indicators driving Scibase AB's intrinsic value. More Info.
Scibase AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scibase AB's earnings, one of the primary drivers of an investment's value.

About Scibase AB Financial Statements

Scibase AB shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Scibase AB investors may analyze each financial statement separately, they are all interrelated. The changes in Scibase AB's assets and liabilities, for example, are also reflected in the revenues and expenses on on Scibase AB's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Scibase Stock Analysis

When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.